FadiSBraitehMD

PubMed

• 1 citations
  Phase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN-mutated advanced solid tumors.
  Shubham Pant, Erika Hamilton, Susanna V Ulahannan, James F Strauss, Fadi S Braiteh, Mo Huang, Danny Chih Hsun Liaw> ;Cancer. 2023 Jun 15
• 7 citations
  Results from Phase 1 Extension Study Assessing Pexidartinib Treatment in 6 cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
  William D. Tap, Arun S. Singh, Stephen P. Anthony, Mike Sterba, Chao Zhang, John H. Healey, Bartosz Chmielowski, Allen Lee Cohn, Geoffrey I. Shapiro, Vicki L. Keedy, Z...> ;Clinical Cancer Research. 2021 Oct 29
• 2 citations
  Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration.
  Siwen Hu-Lieskovan, Fadi Braiteh, Juneko E. Grilley-Olson, Xiao Wang, Alison Forgie, Vinicius Bonato, Ira Jacobs, Jeffrey Chou, Melissa Lynne Johnson> ;Targeted Oncology. 2021 Oct 25
• 36 citations
  Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
  Daniel P. Petrylak, Yohann Loriot, David R. Shaffer, Fadi Braiteh, John D. Powderly, Lauren C. Harshman, Paul Conkling, Jean-Pierre Delord, Michael S. Gordon, Joseph K...> ;Clinical Cancer Research. 2021 Feb 10
• Nivolumab and Ipilimumab Combination Therapy for Second-Line Treatment of Hepatocellular Carcinoma.
  Fadi Braiteh> ;Gastroenterology & Hepatology. 2021 Feb 1
• 14 citations
  A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma.
  Sant P. Chawla, Sanjay Goel, Warren Chow, Fadi Braiteh, Arun S. Singh, Juneko E. Grilley Olson, Atsushi Osada, Iulian Bobe, Richard F. Riedel> ;Clinical Cancer Research. 2020 May 7
• 8 citations
  Corrigendum: Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: A randomized, double...
  Harry H. Yoon, Johanna C. Bendell, Fadi Braiteh, Irfan Firdaus, Philip A. Philip, Allen Lee Cohn, Nancy L. Lewis, Edward Arrowsmith, Jonathan D. Schwartz, Ling Gao, Ya...> ;Annals of Oncology. 2019 Dec 1
• 14 citations
  Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study
  Sarina Anne Piha-Paul, Matthew H. Taylor, Daniel L. Spitz, Lee S. Schwartzberg, J. Thaddeus Beck, Todd M. Bauer, Funda Meric-Bernstam, Das Purkayastha, Linda Karpiak, ...> ;Oncotarget. 2019 Nov 5
• 30 citations
  First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.
  Ignacio Garrido-Laguna, Ian E. Krop, Howard A. Burris, Erika Hamilton, Fadi Braiteh, Amy Weise, Maysa M. Abu-Khalaf, Theresa L. Werner, Steven Pirie-Shepherd, Christop...> ;International Journal of Cancer. 2019 Oct 1
• 4 citations
  Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer.
  Zorawar S. Noor, Jonathan W. Goldman, William E. Lawler, Bijoy Telivala, Fadi Braiteh, B DiCarlo, Kathleen Kennedy, Brad Adams, Xiaoyan Wang, Benjamin P Jones, Dennis ...> ;Lung Cancer. 2019 Sep 1
• 88 citations
  Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers.
  Joyce F. Liu, Michael S. Gordon, Jennifer Taylor Veneris, Fadi Braiteh, Ani Sarkis Balmanoukian, Joseph Paul Eder, Ana Oaknin, Erika Hamilton, Yulei Wang, Indrani Sark...> ;Gynecologic Oncology. 2019 Aug 1
• 40 citations
  Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial.
  Melissa Lynne Johnson, Fadi Braiteh, Juneko E. Grilley-Olson, Jeffrey Chou, Jasmine Davda, Alison Forgie, Ruifeng Li, Ira Jacobs, Farhad Kazazi, Siwen Hu-Lieskovan> ;JAMA Oncology. 2019 Jul 1
• Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.
  Schrock, A. B.,Ouyang, C.,Sandhu, J.,Sokol, E.,Jin, D.,Ross, J. S.,Miller, V. A.,Lim, D.,Amanam, I.,Chao, J.,Catenacci, D.,Cho, M.,Braiteh, F.,Klempner, S. J.,Ali, S. ...> ;Ann. Oncol.. 2019 May 01
• 492 citations
  Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
  Leisha A. Emens, Cristina Cruz, Joseph Paul Eder, Fadi Braiteh, Cathie Chung, Sara M. Tolaney, Irene Kuter, Rita Nanda, Philippe A. Cassier, Jean Pierre Delord, Michae...> ;JAMA Oncology. 2019 Jan 1
• 245 citations
  Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
  Vincenzo Mazzaferro, Bassel F. El-Rayes, Michele Droz dit Busset, Christian Cotsoglou, William P. Harris, Nevena Damjanov, Gianluca Masi, Lorenza Rimassa, Nicola Perso...> ;British Journal of Cancer. 2019 Jan 1
• 16 citations
  Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations o...
  Li-Tzong Chen, Jens T. Siveke, Andrea Wang-Gillam, Chung Pin Li, György Bodoky, Andrew P. Dean, Yan Shen Shan, Gayle S. Jameson, Teresa Macarulla, Kyung Hun Lee, David...> ;European Journal of Cancer. 2018 Dec 1
• 93 citations
  Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial.
  A.D. Colevas, Ratislav Bahleda, Fadi Braiteh, Ani Sarkis Balmanoukian, Irene Brana, Nicole G. Chau, Indrani Sarkar, Luciana Molinero, William Grossman, F. Kabbinavar, ...> ;Annals of Oncology. 2018 Nov 1
• 63 citations
  Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study
  Carlo Gambacorti-Passerini, Sergey Orlov, Li Zhang, Fadi Braiteh, Hui-Qiang Huang, Taito Esaki, Keizo Horibe, Jin Seok Ahn, Joseph Thaddeus Beck, William Jeffrey Edenf...> ;American Journal of Hematology. 2018 May 1
• 27 citations
  Signature program: a platform of basket trials.
  Eric Daniel Slosberg, Barinder P. Kang, Julio Peguero, Matthew H. Taylor, Todd M. Bauer, Donald A. Berry, Fadi Braiteh, Alexander I. Spira, Funda Meric-Bernstam, Steve...> ;Oncotarget. 2018 Apr 20
• 4 citations
  Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patient...
  Sachdev P. Thomas, Lauren E. Jacobson, Anthony R. Victorio, Theresa N. Operana, Brock Schroeder, Catherine A. Schnabel, Fadi Braiteh> ;JCO Precision Oncology. 2018 Mar 5
• 17 citations
  Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis.
  Reshma Mahtani, Monika Parisi, Stefan Glück, Quanhong Ni, Siyeon Park, Corey Pelletier, Claudio Faria, Fadi Braiteh> ;Cancer Management and Research. 2018 Feb 8
• 91 citations
  Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study.
  Daniel P. Petrylak, Thomas Powles, Joaquim Bellmunt, Fadi Braiteh, Yohann Loriot, Rafael Morales-Barrera, Howard A. Burris, Joseph Kim, Beiying Ding, Constanze Kaiser,...> ;JAMA Oncology. 2018 Apr 1
• 26 citations
  Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing
  Alexa B. Schrock, Garrett M. Frampton, Dana Herndon, Joel R. Greenbowe, Kai Wang, Doron Lipson, Roman Yelensky, Zachary R. Chalmers, Juliann Chmielecki, Julia A. Elvin...> ;Clinical Cancer Research. 2016 Mar 1
• 296 citations
  HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Duct...
  Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock, Tara Elisabeth Seery, William P. Harris, Darren Sigal, Fadi Braiteh, Paul S. Ritch, Mark M. Zalupski, Nathan Bahary, ...> ;Journal of Clinical Oncology. 2017 Dec 12
• 5 citations
  Treatment Patterns and Clinical Outcomes in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated in the Community Practice Setting in the Unit...
  Xiaolong Jiao, Sonia Pulgar, Marley Boyd, Fadi Braiteh, Beloo Mirakhur, Susan Pitman Lowenthal, Patricia S. Fox, Jennifer Frytak, David G. Cox, A. Scott Paulson> ;Pancreas. 2017 Dec 1
• Join now to see all

Journal Articles

• Oxford University Press Has Registered This DOI Pre-Publication  
  Fadi Braiteh, MD, Oxford University Press